《超声增强剂在超声心动图中的临床应用:2018美国超声心动图指南更新》及《心脏超声增强剂临床应用规范专家共识》解读
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Explanations of “Clinical Applications of Ultrasonic Enhancing Agentsin Echocardiography 2018 Update” and “Expert consensus on clinical application of cardiac ultrasound contrast agents”
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    超声造影是超声医学发展最重要的技术之一,超声增强剂和心血管超声造影技术的发展,必将对心血管疾病的精准诊断和治疗产生巨大影响。欧洲超声心动图协会和美国超声心动图协会相继在2017 年和2018 年发布了最新声学造影临床应用指南。2019年,《中华医学超声杂志(电子版)》又刊载了“心脏超声增强剂临床应用规范专家共识”。鉴于国内尚未普及超声增强剂在超声心动图中的临床应用,为促进和规范我国心血管超声增强剂的临床应用,本文就“2018美国超声心动图指南更新”和“临床应用规范专家共识”要点进行解读。

    Abstract:

    European Association of Echocardiography (EAE) and American Society of Echocardiography (ASE) released the latest clinical application of ultrasound contrast agents in 2017 and 2018. Chinese translation of "Clinical Applications of Ultrasonic Enhancing Agents (UEA) in Echocardiography 2018 Update" published in Chinese Journal of Ultrasonography, Volume 28, issue 7, July 2019. The introduction of Chinese version will greatly promote the clinical application of ultrasound enhancing agents in echocardiography. In addition, “Expert consensus on clinical application of cardiac ultrasound contrast agents” published in Chinese Journal of medical ultrasound (Electronic Edition), Volume 16, issue 10, October 2019. In consideration of the fact that the clinical application of ultrasound enhancing agents is not widespread in China, and in order to promote and standardize the clinical application of ultrasound enhancing agents, we write this paper. The main points of "2018 ASE guidelines update" and "Expert consensus on clinical application" are as follows.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-04-09
您是第位访问者
版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司